Pharmacist-Led Discharge Care to Reduce Postdischarge Utilization

Pharmacist-led discharge care is an increasingly visible approach to easing the risky period right after a patient leaves the hospital. It aims to reduce postdischarge utilization by catching medication problems, improving adherence, and coordinating follow-up so fewer patients return to the emergency department or are readmitted within weeks of discharge.

Recent Research

A recent randomized clinical trial evaluated the efficacy of the Pharmacist Discharge Care (PHARM-DC) intervention in reducing 30-day postdischarge healthcare utilization. The study analyzed 6,428 hospitalizations of older adults (aged 55 and older) experiencing polypharmacy or using high-risk medications across two urban U.S. teaching hospitals. The intervention consisted of robust, pharmacist-led peri-discharge and post-discharge medication management, including comprehensive medication reviews, reconciliation, and follow-up counseling. Both the intervention and usual care groups received standard admission medication reconciliation.

Ultimately, the trial detected no statistically significant difference in the primary outcome of unplanned, 30-day all-hospital utilization (25.6% intervention vs. 26.4% usual care). Similarly, there was no overall significant reduction in same-hospital unplanned utilization (18.5% intervention vs. 19.5% usual care). Potential confounding factors included trial underenrollment, intervention contamination, and the high quality of baseline usual care.

Crucially, ana priori subgroup analysis of 589 patients with low medication adherence and literacy (MedAL) revealed a significant 10.4 percentage point absolute reduction in same-hospital unplanned utilization. The authors conclude that while universal implementation may not alter broad healthcare utilization, targeting pharmacist transitions-of-care interventions specifically toward patients with low health literacy and adherence improves clinical outcomes and maximizes cost-feasibility.

Why It Matters

The days after a hospital stay are one of the most dangerous stretches in modern health care. Patients leave with new diagnoses, new prescriptions, and instructions that often clash with what their primary care clinician or home support expects. Medication is a central piece of that problem. Errors in reconciling what a patient was taking before admission versus what they should take after discharge are common. So are unclear instructions and gaps in who will refill or monitor high-risk drugs.

When medication problems go unresolved, the result is often avoidable downstream care: urgent visits, readmissions, and a cascade of tests and treatments that drive up costs and harm patients. For clinicians and health systems, this creates both clinical burden and financial pressure. For patients, it means interruptions in recovery, lost time at work, and sometimes catastrophic adverse events. Addressing those gaps is an efficient target for improving outcomes and lowering unnecessary utilization.

Pharmacists have a deep, practical skill set centered on medications. Putting them squarely into the discharge process can change how medication lists are reconciled, how instructions are explained, and how follow-up is arranged. That matters because medication issues are a leading, modifiable driver of postdischarge problems. Done well, pharmacist-led discharge care can shorten the path to safe medication use at home and reduce costly returns to acute care.

Who It Affects

Patients with complex medication regimens are the most obvious beneficiaries. That includes older adults with multiple chronic conditions, people recently started on new high-risk drugs, and patients with limited health literacy or social supports who struggle to follow written instructions. People leaving the hospital after a serious acute illness or surgery are also at higher risk of medication-related complications.

Clinicians and hospital teams see practical benefits too. Physicians and nurses are often stretched thin at discharge and welcome a colleague who can take the time to review medicines, spot dangerous interactions, and clarify dosing. Pharmacists can also reduce the friction of communication between inpatient and outpatient clinicians by documenting changes clearly and recommending follow-up monitoring when needed.

Payers and health system leaders have a stake in how discharge care is organized. Reducing repeat utilization has clear cost implications. But reforms must be weighed against the cost of deploying pharmacists at scale, particularly in systems with thin margins. Policy makers who oversee quality metrics and reimbursement may also consider pharmacist-led models when designing incentives tied to readmissions and postdischarge care.

What Changes

• More thorough medication reconciliation at discharge. Pharmacists systematically compare pre-admission and discharge medications, reducing omissions and duplications that can lead to harm.
• Clear patient counseling and tailored teach-back. Pharmacists spend time with patients and caregivers to explain what each medicine is for, how to take it, and what side effects to watch for. This improves adherence and reduces confusion.
• Proactive follow-up and coordination. Pharmacists arrange postdischarge calls, check for access to prescriptions, and alert outpatient clinicians when monitoring is needed.
• Targeted deprescribing and risk reduction. When appropriate, pharmacists recommend stopping unnecessary medications or adjusting doses for renal function and drug interactions, especially in older adults.

Pharmacist involvement changes the day-to-day work of discharge in specific ways

First, pharmacists are trained to spot drug-drug interactions and dose problems that might not be obvious in a busy ward. Second, they can reconcile the often messy medication lists that travelers through multiple care settings leave behind. Third, they provide the patient-facing counseling that nurses and physicians may not have time for. Those three steps address the most common mechanisms by which medication-related issues translate into postdischarge utilization.

The Challenges of Implementation

But implementation is not without challenge. Hospitals and health systems must decide who performs the service and when. Should pharmacists see every discharged patient, or only those flagged as high risk? Universal coverage is appealing but expensive. Targeted programs are more affordable, but rely on accurate risk stratification. Staffing is another constraint. Many hospitals already have pharmacists focused on medication safety, oncology, and antimicrobial stewardship. Adding discharge responsibilities may require hiring more staff or reshuffling duties. That has cost implications and competing priorities.

Reimbursement and Payment Systems

Reimbursement matters too. Current payment systems do not consistently pay for pharmacist-led transitional care services. Some programs can bill incident-to or use collaborative practice agreements to capture revenue, but this varies by payer and state scope-of-practice rules. Where reimbursement exists, programs are easier to sustain. Where it does not, hospitals must justify pharmacist deployment on the basis of avoided downstream costs and quality metrics, which can be a harder sell for short-term budgets.

Coordination with the help of technology

Technology can help and hinder. Electronic health records (EHRs) can store reconciled medication lists, enable pharmacists to document counseling, and trigger follow-up tasks. But systems often lack interoperability. When a patient’s community pharmacy or primary care clinic uses a different system, important signals can be lost. Telepharmacy and virtual visits expand reach, particularly for rural patients or those discharged at night. Yet virtual care still requires reliable broadband and workflows that integrate with in-person services.

Health Equity as part of the conversation

Equity should be part of this conversation. Patients with limited English proficiency, low health literacy, or unstable housing are at high risk for postdischarge medication problems. Pharmacist-led discharge care that includes interpreter services, culturally tailored counseling, and attention to social needs can narrow disparities. If such services are only offered in certain hospitals or to those with better insurance, the program risks widening inequities.

Clinically, pharmacist-led discharge care shifts some decision-making. Pharmacists are increasingly empowered through collaborative practice agreements to initiate or adjust therapy within agreed protocols. That can speed up transitions and reduce delays in starting indicated treatments. It also raises questions about accountability and communication. Clear documentation and agreed handoffs to primary care remain essential. Clinicians who receive a pharmacist’s recommendations need confidence that changes were explained to the patient and that follow-up is arranged.

Looking Ahead

Looking ahead, several trends will shape how widely pharmacist-led discharge care spreads. Payment reforms that reward outcomes, rather than volume, create incentives for hospitals to invest in transitional care. Growing workforce shortages in nursing and primary care may make pharmacist contributions more valuable. At the same time, training programs for pharmacists are evolving to emphasize clinical skills and direct patient care, which supports broader implementation.

We should be realistic about limits. Pharmacist-led programs are not a cure-all. Some postdischarge utilization stems from social determinants like lack of transportation, food insecurity, or inability to take time off work. Medication-focused interventions must be paired with broader transitional care strategies: arranging outpatient follow-up appointments, connecting patients to home health, and addressing social needs. Also, not every hospital can roll out a full-service pharmacist discharge team overnight. Pilot programs that start with high-risk populations and measure outcomes can guide scale-up.

For clinicians and healthsystem leaders considering this model, practical steps matter. Start by defining the target population. Build simple, measurable processes for reconciliation, counseling, and documentation. Use pharmacists where they add the most value: complex regimens, high-risk medicines, and patients with social barriers. Invest in training and in information exchange. Finally, measure both clinical outcomes and utilization so that the program’s benefits and costs are transparent.

Pharmacist-Led Discharge Care

Pharmacist-led discharge care is a pragmatic, medicine-centered approach to a persistent problem. It recognizes that many avoidable postdischarge events begin with medication confusion or error. It also acknowledges the practical constraints of modern care. When thoughtfully designed and resourced, these programs can reduce unnecessary utilization, make patients safer, and make the rest of the care team’s job easier. The details matter. The payment model matters. But the basic idea is simple. Get the medicines right before patients go home, and fewer patients will need to come back.

Reference

1. Pevnick JM, Kennelty K, Nguyen AT, et al. Pharmacist-Led Discharge Care to Reduce Postdischarge Health Care Utilization: A Randomized Clinical Trial. JAMA Netw Open. 2026;9(3):e260719. Published 2026 Mar 2. doi:10.1001/jamanetworkopen.2026.0719